AI assistant
TALPHERA, INC. — Director's Dealing 2013
May 29, 2013
35181_dirs_2013-05-29_4e841396-d3f9-4774-a605-8df5a5ec39c3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2013-05-24
Reporting Person: ADAMS ADRIAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-24 | Common Stock | P | 25000 | $7.78 | Acquired | 25000 | Direct |
| 2013-05-28 | Common Stock | P | 50000 | $8.39 | Acquired | 75000 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide AcelRx Pharmaceuticals, Inc. any security holder of AcelRx Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price.
F2: The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide AcelRx Pharmaceuticals, Inc. any security holder of AcelRx Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price.